Skip to main navigation Skip to search Skip to main content

A Phase 3, 12-week, Multicenter, Randomized, Double-Blind, Placebo controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Flexible Dosing of Brexpiprazole (OPC 34712) in the Treatment of Subjects with Agitation Associated wi

Project: Research

Project Details

StatusFinished
Effective start/end date10/1/13 → 09/30/17

Funding

  • INC Research LLC: $19,805.90